57 results
6-K
EX-99.7
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
by the Company. Where the Company has control over an investee, it is classified as a subsidiary. The Company controls an investee if all three of the following … as at September 24, 2019. The CVRs have been classified as a financial liability in the Condensed Consolidated Statement of Financial Position. Given
6-K
EX-99.5
AMYT
Amryt Pharma Plc
4 Aug 22
Results of Annual General Meeting
7:38am
, it is classified as a subsidiary. The Company controls an investee if all three of the following elements are present: power over an investee, exposure or rights … of the acquisition and, accordingly, have been based on fair value as at September 24, 2019. The CVRs have been classified as a financial liability
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
5:06pm
provides otherwise, in the case of a corporation whose board of directors is classified, shareholders may effect such removal only for cause, or (b
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
4:58pm
otherwise, in the case of a corporation whose board of directors is classified, shareholders may effect such removal only for cause, or (b … classified as partnership for U.S. federal income tax purposes or investors therein;
persons who own or are deemed to own, directly or indirectly, 10
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
4:57pm
otherwise, in the case of a corporation whose board of directors is classified, shareholders may effect such removal only for cause, or (b) in the case … . Holders whose functional currency is not the U.S. dollar;
any entity or arrangement classified as partnership for U.S. federal income tax purposes
F-3
5q10mnoj tu6a1
11 May 22
Shelf registration (foreign)
5:22pm
POS AM
appowwe
11 May 22
Prospectus update (post-effective amendment)
5:20pm
POS AM
dhiex8kwmpv9 aze7mc
11 May 22
Prospectus update (post-effective amendment)
5:19pm
6-K
EX-99.2
p9qv06erdax55l20r
11 May 22
Current report (foreign)
4:30pm
424B3
s37xa4zsg1g yfyybm4
4 May 22
Prospectus supplement
8:35am
424B3
57jgprho4f
4 May 22
Prospectus supplement
7:45am
6-K
EX-99.1
qtf3hl7iav311p3x
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am
424B3
ndcocx81b l0
9 Mar 22
Prospectus supplement
9:26am
424B3
bz2hz0drgr
9 Mar 22
Prospectus supplement
9:25am
6-K
EX-99.1
u2v5ce0f
9 Mar 22
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
9:23am
6-K
EX-99.1
31w235s6r7kmuexf
25 Feb 22
Current report (foreign)
4:05pm
424B3
nn8 xi45zd
3 Nov 21
Prospectus supplement
7:33am
424B3
ufdh zowad9aldow
3 Nov 21
Prospectus supplement
7:32am